Antigenics to Webcast 2010 Annual Shareholders Meeting

LEXINGTON, Mass.--(BUSINESS WIRE)-- Antigenics Inc. (NASDAQ: AGEN) invites investors and the general public to its 2010 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, May 12. The meeting will be held at the company's headquarters at 3 Forbes Road, Lexington, MA 02421. Registration for attendees starts at 4:30 p.m. ET.

A live webcast will be accessible from the company’s website at www.antigenics.com/webcast/ and will be archived and available for replay approximately two hours after the meeting.

Antigenics is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit www.antigenics.com.



CONTACT:

Antigenics
Media: Brad Miles, 212-477-9007 x 17
or
Investors:
Shalini Sharp, 800-962-2436

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Infectious Diseases  Oncology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

German researchers uncovered 28 antibodies that neutralize COVID-19 and are working with Boehringer Ingelheim to advance them into clinical testing.

Oragenics is ending a phase 2 study of its oral mucositis drug, yanking its IND application and switching its focus to a COVID-19 vaccine.

The vehicle, which Blackstone claims is the largest life sciences private fund, has committed close to $1 billion to companies including Alnylam.